Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11344564 Method of treatment based on reduced monoamine oxidase a activity

Patent 11344564 was granted and assigned to Lennham Pharmaceuticals on May, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

Provided herein are methods for the safe use of compositions comprising psilocin and prodrugs of psilocin for treating and/or preventing various diseases and conditions, such as mood or psychiatric disorders.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11344564 Method of treatment based on reduced monoamine oxidase a activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo